It is a pharma private limited company based in Secunderabad, Telangana, India, established in 2021.
2021 | Secunderabad, Telangana, India | ActiveSri Lakshmi Drugs & Chemicals Private Limited, a active private limited company, was established on 18 January 2021 in Secunderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33309TG2021PTC147825. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹6.75 Cr.
It upholds a compliant status. Its leadership includes Naga Phaneendra Manney (Additional Director), Madhu Bojedla (Director). Past directors included Suresh Samineni. It holds ₹4.62 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2021, with the balance sheet filed on 31 March 2021. It is based at D.No.102, 10-01-1/2/218 & 219 1St Floor Trilok Jmr Green Wood,, Block-A, Bhavani Nagar Colony Gate-2 Chakripuram Chowrasta Cherla Pally,, Secunderabad, Telangana, 500062.
U33309TG2021PTC147825
147825
18 January 2021
₹7.00 Cr
₹6.75 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sri Lakshmi Drugs & Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naga Phaneendra Manney | Additional Director | 19 Jan 2021 | Current |
| Madhu Bojedla | Director | 18 Jan 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Mar 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Sri Lakshmi Drugs & Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2021, Sri Lakshmi Drugs & Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹46,247,013.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2023 | Canara Bank | ₹5.00 M | Open |
| 31 Mar 2023 | Axis Bank Limited | ₹1.25 M | Open |
| 12 Apr 2022 | Canara Bank | ₹4.00 Cr | Open |
Explore comprehensive loan charge details -
Sri Lakshmi Drugs & Chemicals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sri Lakshmi Drugs & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Lakshmi Drugs & Chemicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Canara Bank amounted to Rs. 0.50 Cr with Charge ID 100847529 was registered on 26 Sep 2023. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 0.12 Cr with Charge ID 100747176 was registered on 31 Mar 2023. was completed.
Progress on A charge with Canara Bank amounted to Rs. 4.00 Cr with Charge ID 100568051 was registered on 12 Apr 2022. was documented.
The activity Sri Lakshmi Drugs & Chemicals Private Limited last Annual general meeting of members was held on 30 Sep 2021 as per latest MCA records. was completed.
Sri Lakshmi Drugs & Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was recorded as a recent event.
The activity Naga Phaneendra Manney was appointed as a Additional Director was appointed as a Additional Director on 19 Jan 2021 & has been associated with this company since 4 years 10 months . was completed.
The CIN of Sri Lakshmi Drugs & Chemicals Private Limited is U33309TG2021PTC147825.
Sri Lakshmi Drugs & Chemicals Private Limited is headquartered at D.No.102, 10-01-1/2/218 & 219 1St Floor Trilok Jmr Green Wood,, Block-A, Bhavani Nagar Colony Gate-2 Chakripuram Chowrasta Cherla Pally,, Secunderabad, Telangana, 500062.
Sri Lakshmi Drugs & Chemicals Private Limited was incorporated on 18 January 2021.
The current directors of Sri Lakshmi Drugs & Chemicals Private Limited are
The primary industry of Sri Lakshmi Drugs & Chemicals Private Limited is Manufacturing.
Sri Lakshmi Drugs & Chemicals Private Limited is unlisted.
The authorized capital of Sri Lakshmi Drugs & Chemicals Private Limited is ₹7.00 Cr, and the paid-up capital is ₹6.75 Cr.
The compliance status of Sri Lakshmi Drugs & Chemicals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX